The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMYSL.L Regulatory News (MYSL)

  • There is currently no data for MYSL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) MySale Group PLC

2 Sep 2022 17:59

RNS Number : 1808Y
MySale Group PLC
02 September 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

MySale Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MySale Group plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

2 September 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary Shares of no par value

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0.00

Nil

0.00

(2) Cash-settled derivatives:

 

Nil

0.00

Nil

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0.00

Nil

0.00

 

TOTAL:

Nil

0.00

Nil

0.00

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

a) Holdings of ordinary shares by directors of MySale Group plc:

 

Name

No. Ordinary Shares held

% of total issued share capital carrying voting rights

Carl Jackson

103,745,000

10.93

 

Kalman Polak1

13,100,888

1.38

 

Charles Butler

17,000

0.00

 

Note

1. These shares reflect loan shares issued under the MySale Loan Share Plan on 1 July 2021. These shares have been issued by the Company and carry voting rights and remain subject to the rules of the MySale Loan Share Plan.

 

b) Holdings of ordinary shares by parties deemed to be acting in concert with MySale Group Plc:

 

Name

No. Ordinary Shares held

% of total issued share capital carrying voting rights

MySale Group Trustee Limited ("EBT")1

7,542,614

0.79

Jamie Jackson

62,145,285

6.55

Gabby Leibovich

34,090,051

3.59

Hezi Leibovich

34,090,051

3.59

Nati Harpaz

28,138,415

2.96

Note

1. The Company's employee benefit trust ("EBT"), of which MySale Group Trustee Limited (the "Trustee") is trustee, holds 7,542,614 ordinary shares in the Company. Carl Jackson and Charles Butler are the directors of the Trustee. Ordinary shares held by the EBT, under the rules of the EBT, are not voted.

 

 

c) The directors of the Company have the following rights to subscribe for the following relevant MySale securities under share option plans:

Name

Plan

Date of Grant

Vesting period

Exercise price (pence)

No. of options outstanding

Charles Butler

MySale Share Option Scheme

05.12.2019

3 years from issue

2.0p

5,625,000

Charles Butler

MySale JSOP Scheme

05.12.2019

3 years from issue

2.0p

5,625,000

 

 

 

 

 

d) The following directors of the Company and Nati Harpaz have the following rights to subscribe for the following relevant MySale securities on the conversion of Loan Notes:

Name

Amount

A$

% of Loan Notes issued

Amount

£ equivalent

No. of Ordinary shares on conversion1

Carl Jackson

A$1,100,000

47.83

£628,571.43

41,904,762

Kalman Polak

A$950,000

41.30

£542,857.14

36,190,476

Nati Harpaz

A$250,000

10.87

£142,857.14

9,523,810

 

 

 

 

Notes

1. Excluding any roll-up of interest on conversion. The Loan Notes have a maturity date of 30 April 2025 and are convertible into ordinary shares of the Company at a conversion price of 1.5 pence (or A$0.02625, with exchange rate fixed at GBP:AUD rate of 1.75), per ordinary share, at the election of the Loan Note holders, at any time prior to maturity. The Loan Notes may be redeemed by the Group at any time prior to maturity, without penalty. Interest will be payable at a rate of 7% per annum, paid-in-kind in ordinary shares in the Group.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

2 September 2022

Contact name:

Carl Jackson

Telephone number:

+61 414 817 843

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEQLLFBLKLEBBD
Date   Source Headline
18th Jul 20224:35 pmRNSPrice Monitoring Extension
1st Jul 20228:31 amRNSHolding(s) in Company
28th Jun 202210:06 amRNSBoard Change
26th Apr 20222:30 pmRNSBoard Change
1st Apr 20224:41 pmRNSSecond Price Monitoring Extn
1st Apr 20224:36 pmRNSPrice Monitoring Extension
31st Mar 202212:40 pmRNSIssue of Convertible Loan Notes
31st Mar 202212:40 pmRNSHalf Year Results
4th Mar 20224:40 pmRNSSecond Price Monitoring Extn
4th Mar 20224:35 pmRNSPrice Monitoring Extension
18th Feb 20224:36 pmRNSPrice Monitoring Extension
15th Feb 20227:09 amRNSTrading Update
10th Jan 20227:00 amRNSDirectorate Change
29th Dec 20217:00 amRNSDirectorate Change
9th Dec 20214:41 pmRNSSecond Price Monitoring Extn
9th Dec 20214:36 pmRNSPrice Monitoring Extension
7th Dec 20214:40 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
29th Nov 20216:20 pmRNSResult of AGM
25th Nov 20211:15 pmRNSUpdate on ASX IPO
12th Nov 20217:00 amRNSFurther instructions for AGM
11th Nov 20211:00 pmRNSPublication and despatch of Circular
4th Nov 20211:16 pmRNSNotice of AGM
4th Nov 20211:15 pmRNSProposed Listing on ASX
21st Oct 20214:41 pmRNSSecond Price Monitoring Extn
21st Oct 20214:35 pmRNSPrice Monitoring Extension
12th Oct 20214:41 pmRNSSecond Price Monitoring Extn
12th Oct 20214:36 pmRNSPrice Monitoring Extension
8th Oct 20214:40 pmRNSSecond Price Monitoring Extn
8th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20214:40 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
5th Oct 20217:01 amRNSFinal Results
5th Oct 20217:00 amRNSAppointment of CEO and Board Update
2nd Sep 20214:41 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:36 pmRNSPrice Monitoring Extension
24th Aug 20214:40 pmRNSSecond Price Monitoring Extn
24th Aug 20214:35 pmRNSPrice Monitoring Extension
20th Aug 20214:36 pmRNSPrice Monitoring Extension
12th Aug 20214:40 pmRNSCorrection: PDMR Dealing
12th Aug 202110:00 amRNSPDMR Dealing
30th Jul 20214:41 pmRNSSecond Price Monitoring Extn
30th Jul 20214:35 pmRNSPrice Monitoring Extension
21st Jul 20217:00 amRNSFull Year Trading Update
19th Jul 20214:36 pmRNSPrice Monitoring Extension
24th Jun 20214:41 pmRNSSecond Price Monitoring Extn
24th Jun 20214:36 pmRNSPrice Monitoring Extension
18th Jun 20214:41 pmRNSSecond Price Monitoring Extn
18th Jun 20214:36 pmRNSPrice Monitoring Extension
15th Jun 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.